Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study

Pharmacologic and Endovascular Reversal of Left Ventricular Remodeling

(2016) Abhishek Jaiswal et al.   JOURNAL OF CARDIAC FAILURE

Stem cell therapy for heart failure: Ensuring regenerative proficiency

(2016) Andre Terzic et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial

(2015) M. St. John Sutton et al.   Circulation-Heart Failure

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design

(2015) Jozef Bartunek et al.   EUROPEAN JOURNAL OF HEART FAILURE

The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: Results of the REVERSE study

(2015) Michael R. Gold et al.   HEART RHYTHM

Effects of Transendocardial CD34 + Cell Transplantation in Patients With Ischemic Cardiomyopathy

(2014) Gregor Poglajen et al.   Circulation-Cardiovascular Interventions

Location, location, location! Is it important with cell delivery?

(2013) Timothy D. Henry et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Optimized Delivery System Achieves Enhanced Endomyocardial Stem Cell Retention

(2013) Atta Behfar et al.   Circulation-Cardiovascular Interventions

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial

(2013) Timothy J. Collier et al.   EUROPEAN HEART JOURNAL

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study

(2013) Cecilia Linde et al.   EUROPEAN HEART JOURNAL

Cardiopoietic Stem Cell Therapy in Heart Failure

(2013) Jozef Bartunek et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model

(2012) Arun Kumar et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

(2012) Stuart J. Pocock et al.   EUROPEAN HEART JOURNAL

Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy

(2012) Joshua M. Hare et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiac remodelling and myocardial recovery: lost in translation?

(2010) Douglas L. Mann et al.   EUROPEAN JOURNAL OF HEART FAILURE

Cells as biologics for cardiac repair in ischaemic heart failure

(2010) J. Bartunek et al.   HEART

Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction

(2010) Daniel G. Kramer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY